Drug royalty trustIncome
Long-term pharma royalty cash flows; public-listed
Source: quantpedia.com
Healthcare REITIncome
Senior housing/medical office healthcare REITs
Source: quantpedia.com
2026 revenue declines
GLP-1 NovoShort
Novo 2026 revenue declines US pricing
Source: Seeking
ARKG ARK Genomic Revolution
BiotechMulti
ARKG ARK Genomic Revolution ETF
Source: encyclopedia
AbbVie ABBV Humira LOE
SectorMulti
AbbVie ABBV Humira LOE biosimilars
Source: encyclopedia
AbbVie ABBV Humira biosimilar
Big PharmaMulti
AbbVie ABBV Humira biosimilars Skyrizi/Rinvoq
Source: encyclopedia
Abbott ABT diversified
Med DeviceLong
Abbott ABT diversified med + nutrition
Source: encyclopedia
Abbott ABT diversified
MedTechLong
Abbott Labs ABT diversified diagnostics+nutrition
Source: encyclopedia
Aging population demographic
SectorLong
Aging population demographic tailwind
Source: Schwab
Alnylam ALNY RNAi
Biotech InnovatorsLong
Alnylam ALNY RNAi pioneer
Source: encyclopedia
Altimmune AMUN GLP+glucagon
GLP-1 OtherMulti
Altimmune AMUN GLP+glucagon agonist
Source: encyclopedia
Amgen AMGN largest US
BiotechLong
Amgen AMGN largest US biotech
Source: encyclopedia
Amgen MariTide
GLP-1 OtherMulti
Amgen MariTide GLP-1 obesity pipeline
Source: encyclopedia
Amycretin dual-action
GLP-1 NovoLong
Amycretin dual-action weight loss
Source: Fool
Argenx ARGX
Biotech InnovatorsLong
Argenx ARGX FcRn antibodies
Source: encyclopedia
AstraZeneca AZN UK
SectorLong
AstraZeneca AZN UK pharma oncology
Source: encyclopedia
AstraZeneca AZN diversified
Big PharmaLong
AstraZeneca AZN UK diversified
Source: encyclopedia
Axsome Therapeutics AXSM
Biotech InnovatorsLong
Axsome Therapeutics AXSM CNS
Source: Markethost
Bayer German pharma
Big PharmaMulti
Bayer German pharma + agrichem
Source: encyclopedia
Beam Therapeutics BEAM editing
Cell TherapyMulti
Beam Therapeutics base editing
Source: encyclopedia
Becton Dickinson BDX
MedTechLong
Becton Dickinson BDX medical devices + diagnostics
Source: encyclopedia
BioMarin BMRN rare
Biotech InnovatorsMulti
BioMarin BMRN rare disease
Source: encyclopedia
BioNTech BNTX mRNA
Biotech InnovatorsMulti
BioNTech mRNA + cancer pipeline
Source: encyclopedia
BioNTech BNTX mRNA
BiotechMulti
BioNTech BNTX mRNA Pfizer COVID partner
Source: encyclopedia
Biogen BIIB Alzheimer's
BiotechMulti
Biogen BIIB Alzheimer's Leqembi
Source: encyclopedia
Boston Scientific BSX
Med DeviceLong
Boston Scientific BSX cardiology
Source: encyclopedia
Boston Scientific BSX
MedTechMulti
Boston Scientific BSX cardiovascular + EP
Source: encyclopedia
Breyanzi BMS
CAR-TLong
Breyanzi BMS CAR-T
Source: encyclopedia
Bristol-Myers BMY Eliquis
Big PharmaMulti
Bristol-Myers BMY Eliquis franchise
Source: encyclopedia
CAR-T cell therapy theme
CAR-TLong
CAR-T cell therapy oncology
Source: encyclopedia
CRISPR Therapeutics CRSP
Cell TherapyLong
CRISPR Therapeutics CRSP gene editing
Source: Yahoo
CVS Health CVS pharmacy + Aetna
SectorMulti
CVS Health pharmacy + Aetna + Caremark PBM
Source: encyclopedia
CVS Health CVS pharmacy + ins
Insurance/PBMMulti
CVS Health CVS pharmacy + insurance
Source: encyclopedia
CagriSema cagrilintide+sema
GLP-1 NovoLong
CagriSema once-weekly cagrilintide + semaglutide
Source: Fool
Caribou CRBU allogeneic
Cell TherapyMulti
Caribou Biosciences CRBU allogeneic
Source: encyclopedia
Carvykti J&J Legend
CAR-TLong
Carvykti J&J Legend CAR-T multiple myeloma
Source: encyclopedia
Casgevy CRISPR partnership
Cell TherapyLong
Casgevy with CRSP - sickle cell + thalassemia
Source: Yahoo
Centene CNC Medicaid
SectorMulti
Centene CNC Medicaid managed care
Source: encyclopedia
Cigna CI Evernorth
Insurance/PBMMulti
Cigna CI Evernorth PBM Express Scripts
Source: encyclopedia
Cigna CI insurer + Express Scripts
SectorMulti
Cigna CI + Express Scripts PBM
Source: Gotrade
Combination regimens future
GLP-1 IndustryLong
Combination regimens future of obesity
Source: CNBC
Danaher DHR life sciences
ToolsLong
Danaher DHR diagnostics + tools
Source: encyclopedia
Danaher DHR life sciences
MedTechLong
Danaher DHR life sciences + diagnostics conglomerate
Source: encyclopedia
Dexcom DXCM CGM
Med DeviceLong
Dexcom DXCM CGM continuous glucose
Source: encyclopedia
Direct-to-consumer growing
GLP-1 IndustryLong
DTC GLP-1 market growing slice
Source: CNBC
EPS forecast $35 2026
GLP-1 IndustryLong
Lilly forecast EPS $35 in 2026
Source: Seeking
Editas Medicine EDIT
Cell TherapyMulti
Editas Medicine EDIT gene editing
Source: encyclopedia
Edwards Lifesciences EW
Med DeviceLong
Edwards Lifesciences EW heart valves
Source: encyclopedia
Edwards Lifesciences EW TAVR
MedTechMulti
Edwards Lifesciences EW TAVR heart valve
Source: encyclopedia
Elevance ELV BCBS
SectorMulti
Elevance Health ELV BCBS plans
Source: encyclopedia
Elevance ELV BlueCross
Insurance/PBMMulti
Elevance Health ELV BlueCross
Source: encyclopedia
Eli Lilly LLY GLP-1
SectorLong
Eli Lilly LLY GLP-1 obesity Mounjaro/Zepbound
Source: Investing
Eli Lilly LLY largest cap pharma
Big PharmaLong
Eli Lilly LLY largest cap pharma
Source: Fool
Eli Lilly Point Biopharma
RadiopharmaceuticalMulti
Lilly acquired Point Biopharma $1.4B 2023
Source: encyclopedia
First CRISPR FDA approved 2023
Cell TherapyLong
First CRISPR therapy FDA approval Dec 2023
Source: encyclopedia
GLP-1 megatrend obesity
GLP-1 IndustryLong
GLP-1 obesity drug megatrend pharma decade
Source: Markethost
GSK GlaxoSmithKline
SectorMulti
GSK GlaxoSmithKline UK pharma
Source: encyclopedia
GSK plc UK
Big PharmaMulti
GSK plc UK pharma
Source: encyclopedia
Gilead GILD HIV + oncology
Biotech InnovatorsMulti
Gilead GILD HIV franchise + oncology
Source: encyclopedia
Gilead GILD HIV oncology
BiotechMulti
Gilead Sciences GILD HIV + oncology
Source: encyclopedia
Humana HUM Medicare focus
SectorMulti
Humana HUM Medicare Advantage focus
Source: encyclopedia
IBB iShares Biotech ETF
BiotechLong
IBB iShares Biotechnology ETF
Source: encyclopedia
IXJ iShares Global Healthcare
SectorMulti
IXJ iShares Global Healthcare ETF
Source: encyclopedia
Insurance access expanding
GLP-1 IndustryLong
Insurance access for GLP-1 expanding
Source: CNBC
Intellia NTLA in vivo
Cell TherapyMulti
Intellia NTLA in vivo CRISPR
Source: encyclopedia
Intuitive Surgical ISRG
Med DeviceLong
Intuitive Surgical ISRG da Vinci
Source: encyclopedia
Intuitive Surgical ISRG da Vinci
MedTechLong
Intuitive Surgical ISRG da Vinci robot
Source: Gotrade
Ionis IONS antisense
Biotech InnovatorsMulti
Ionis IONS antisense oligonucleotides
Source: encyclopedia
J&J JNJ diversified pharma
Big PharmaLong
Johnson & Johnson JNJ diversified
Source: encyclopedia
JNJ Johnson & Johnson
SectorLong
Johnson & Johnson JNJ pharma + medtech
Source: Investing
Keytruda losing exclusivity
Big PharmaShort
Keytruda LOE coming late decade
Source: encyclopedia
LLY top XLV holding
SectorLong
LLY top XLV holding by weight 2026
Source: Investing
Lantheus LNTH imaging
RadiopharmaceuticalLong
Lantheus LNTH radiopharmaceuticals
Source: encyclopedia
Lilly $1T healthcare 2025
GLP-1 IndustryLong
Lilly first $1T healthcare stock 2025
Source: CNBC
Lilly +40% 2025
GLP-1 IndustryLong
Lilly +40% in 2025
Source: CNBC
Lilly Direct DTC platform
GLP-1 LillyLong
LillyDirect DTC platform
Source: encyclopedia
Lutathera Novartis NET
RadiopharmaceuticalLong
Lutathera Novartis neuroendocrine
Source: encyclopedia
Manufacturing disadvantage
GLP-1 NovoShort
Novo manufacturing scale disadvantage
Source: Seeking
Medicare ban being knocked
GLP-1 IndustryLong
Medicare GLP-1 ban being lifted
Source: CNBC
Medtronic MDT diversified
Med DeviceMulti
Medtronic MDT diversified med device
Source: encyclopedia
Medtronic MDT largest
MedTechMulti
Medtronic MDT largest medtech
Source: encyclopedia
Merck MRK Keytruda
Big PharmaLong
Merck MRK Keytruda PD-1
Source: encyclopedia
Merck MRK Keytruda LOE 2028
SectorMulti
Merck MRK Keytruda blockbuster LOE 2028
Source: encyclopedia
Moderna MRNA mRNA
Biotech InnovatorsMulti
Moderna mRNA platform
Source: encyclopedia
Moderna MRNA mRNA platform
BiotechMulti
Moderna MRNA mRNA platform post-COVID
Source: encyclopedia
Mounjaro tirzepatide diabetes
GLP-1 LillyLong
Mounjaro tirzepatide diabetes
Source: Fool
Muscle-preserving variants
GLP-1 IndustryLong
Muscle-preserving GLP-1 variants in pipeline
Source: CNBC
Neurocrine NBIX
Biotech InnovatorsLong
Neurocrine NBIX neurology
Source: Markethost
Novartis NVS Swiss
Big PharmaMulti
Novartis NVS Swiss pharma
Source: encyclopedia
Novartis NVS Swiss pharma
SectorMulti
Novartis NVS Swiss pharma
Source: encyclopedia
Novo Nordisk NVO Danish
Big PharmaMulti
Novo Nordisk NVO Danish dual
Source: Fool
Novo Nordisk NVO Ozempic Wegovy
SectorLong
Novo Nordisk NVO Ozempic + Wegovy GLP-1
Source: encyclopedia
Oral GLP-1 next phase 2026
GLP-1 IndustryLong
Oral GLP-1 pills next phase 2026
Source: CNBC
Oral GLP-1 obesity Dec 2025
GLP-1 NovoLong
Novo oral GLP-1 obesity FDA Dec 2025
Source: CNBC
Orforglipron oral GLP-1
GLP-1 LillyLong
Orforglipron oral GLP-1 pipeline
Source: Fool
Ozempic semaglutide diabetes
GLP-1 NovoLong
Ozempic semaglutide T2 diabetes
Source: Fool
Patent expiry pressure
GLP-1 NovoShort
Patent expiry pressure on Novo
Source: Seeking
Pfizer GIP receptor blocker
GLP-1 OtherLong
Pfizer GIP receptor blocker pipeline
Source: CNBC
Pfizer Metsera $10B acquisition
GLP-1 OtherMulti
Pfizer acquired Metsera $10B obesity
Source: CNBC
Pfizer PFE Comirnaty Eliquis
SectorMulti
Pfizer PFE Comirnaty + Eliquis post-COVID
Source: encyclopedia
Pfizer PFE post-COVID
Big PharmaMulti
Pfizer PFE post-COVID transition
Source: encyclopedia
Pluvicto Novartis prostate
RadiopharmaceuticalLong
Pluvicto Novartis prostate cancer
Source: encyclopedia
Radiopharma renaissance
RadiopharmaceuticalLong
Radiopharmaceutical renaissance theme
Source: encyclopedia
RayzeBio BMS $4.1B
RadiopharmaceuticalMulti
BMS acquired RayzeBio $4.1B 2024
Source: encyclopedia
Regeneron REGN
BiotechMulti
Regeneron REGN Eylea + Dupixent
Source: encyclopedia
Regeneron REGN Eylea
Biotech InnovatorsLong
Regeneron REGN Eylea + Dupixent
Source: Yahoo
Retatrutide triple agonist
GLP-1 LillyLong
Retatrutide triple agonist GLP/GIP/glucagon
Source: encyclopedia
Roche Carmot acquired
GLP-1 OtherMulti
Roche acquired Carmot obesity 2024
Source: encyclopedia
Roche RHHBY Swiss
Big PharmaLong
Roche RHHBY Swiss diagnostics + pharma
Source: encyclopedia
Roche RHHBY Swiss diagnostics+pharma
SectorLong
Roche RHHBY Swiss diagnostics + pharma
Source: IG
Rybelsus oral semaglutide
GLP-1 NovoLong
Rybelsus oral semaglutide T2 diabetes
Source: Fool
Sanofi SNY French
Big PharmaMulti
Sanofi SNY French pharma
Source: encyclopedia
Sanofi SNY French
SectorMulti
Sanofi SNY French pharma
Source: encyclopedia
Sarepta SRPT DMD
Biotech InnovatorsMulti
Sarepta SRPT Duchenne therapies
Source: encyclopedia
Sleep apnea indication
GLP-1 LillyLong
Tirzepatide approved for sleep apnea
Source: Fool
Stock plummeted on guidance cuts
GLP-1 NovoShort
Novo plummeted on multiple guidance cuts
Source: Fool
Structure Therapeutics oral
GLP-1 OtherMulti
Structure Therapeutics oral GLP-1
Source: encyclopedia
Stryker SYK ortho
MedTechMulti
Stryker SYK orthopedic
Source: encyclopedia
Stryker SYK ortho + neuro
Med DeviceLong
Stryker SYK orthopedic
Source: encyclopedia
Takeda Japanese
Big PharmaMulti
Takeda Japanese pharma
Source: encyclopedia
Takeda TAK Japan
SectorMulti
Takeda TAK Japan pharma global
Source: encyclopedia
Tecartus Gilead
CAR-TLong
Tecartus Gilead CAR-T MCL
Source: encyclopedia
Telix TLX
RadiopharmaceuticalMulti
Telix Pharmaceuticals TLX
Source: encyclopedia
Thermo Fisher TMO
ToolsLong
Thermo Fisher TMO life sciences tools
Source: encyclopedia
Tirzepatide $24.8B 9M 2025
GLP-1 IndustryLong
Tirzepatide $24.8B 9M 2025 best-selling drug
Source: Fool
Trulicity dulaglutide diabetes
GLP-1 LillyMulti
Trulicity dulaglutide GLP-1
Source: Fool
UNH OptumRx PBM
SectorLong
UnitedHealth OptumRx PBM vertically integrated
Source: encyclopedia
UnitedHealth UNH
Insurance/PBMLong
UnitedHealth UNH largest US payer
Source: Markethost
UnitedHealth UNH largest insurer
SectorLong
UnitedHealth UNH largest US health insurer
Source: Investing
VHT Vanguard Health Care
SectorLong
VHT Vanguard Health Care ETF
Source: encyclopedia
Vertex VRTX CF + sickle
Biotech InnovatorsLong
Vertex VRTX cystic fibrosis + sickle
Source: Yahoo
Vertex VRTX cystic fibrosis
Cell TherapyLong
Vertex VRTX cystic fibrosis $10B core
Source: Yahoo
Vertex VRTX cystic fibrosis
BiotechLong
Vertex VRTX cystic fibrosis monopoly + Casgevy
Source: encyclopedia
Vertex non-opioid pain
Cell TherapyLong
Vertex non-opioid Suzetrigine approved 2025
Source: Yahoo
Verve VERV cardiovascular
Cell TherapyMulti
Verve Therapeutics base editing CVD
Source: encyclopedia
Viking VKTX dual amylin
GLP-1 OtherLong
Viking Therapeutics VK2735 obesity
Source: encyclopedia
Wave Life Sciences fat-burning
GLP-1 OtherMulti
Wave Life Sciences fat-burning approach
Source: CNBC
Wegovy semaglutide obesity
GLP-1 NovoLong
Wegovy semaglutide obesity
Source: Fool
XBI SPDR Biotech equal-weight
BiotechLong
XBI SPDR Biotech ETF equal-weight
Source: encyclopedia
XBI biotech ETF
ETFsLong
SPDR XBI biotech ETF
Source: encyclopedia
XLV health care ETF
ETFsLong
SPDR XLV healthcare sector ETF
Source: encyclopedia
XLV largest sector ETF
SectorLong
XLV Health Care Select Sector SPDR
Source: Investing
Yescarta Gilead
CAR-TLong
Yescarta Gilead CAR-T DLBCL
Source: encyclopedia
Zepbound tirzepatide obesity
GLP-1 LillyLong
Zepbound tirzepatide obesity
Source: Fool
An encyclopedia of publicly documented strategies for education. YCAI does not recommend, endorse, or trade any of these. Not investment advice.